Thermo Fisher Scientific Inc (NYSE:TMO) Shares Sold by Forsta AP Fonden

Forsta AP Fonden decreased its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 11.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 160,470 shares of the medical research company’s stock after selling 21,600 shares during the period. Forsta AP Fonden’s holdings in Thermo Fisher Scientific were worth $27,997,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Proficio Capital Partners LLC increased its position in Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares in the last quarter. Cribstone Capital Management LLC increased its position in Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after buying an additional 50 shares in the last quarter. CWM LLC increased its position in Thermo Fisher Scientific by 17.0% in the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 103 shares in the last quarter. Independent Portfolio Consultants Inc. increased its position in Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares in the last quarter. Finally, Sharkey Howes & Javer increased its position in Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares in the last quarter. 87.60% of the stock is currently owned by institutional investors.

Thermo Fisher Scientific Inc (TMO) traded down 0.19% during midday trading on Friday, reaching $172.57. 1,182,702 shares of the company traded hands. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $182.87. The stock has a market capitalization of $67.32 billion, a price-to-earnings ratio of 30.06 and a beta of 1.06. The firm has a 50 day moving average of $176.71 and a 200-day moving average of $166.56.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.03 EPS. Analysts forecast that Thermo Fisher Scientific Inc will post $9.24 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.45%.

TRADEMARK VIOLATION WARNING: “Thermo Fisher Scientific Inc (NYSE:TMO) Shares Sold by Forsta AP Fonden” was originally posted by Community Financial News and is owned by of Community Financial News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.com-unik.info/2017/08/19/thermo-fisher-scientific-inc-nysetmo-shares-sold-by-forsta-ap-fonden-updated.html.

A number of equities analysts have weighed in on the stock. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 price target on the stock in a research note on Tuesday, August 1st. Deutsche Bank AG set a $200.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Saturday, June 10th. BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Barclays PLC reaffirmed an “overweight” rating and set a $200.00 price target (up previously from $190.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 17th. Finally, Wells Fargo & Company reissued an “outperform” rating and issued a $200.00 target price (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. One investment analyst has rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $188.56.

In other Thermo Fisher Scientific news, insider Daniel P. Shine sold 4,688 shares of the business’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $171.88, for a total value of $805,773.44. Following the sale, the insider now owns 29,200 shares of the company’s stock, valued at approximately $5,018,896. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Marc N. Casper sold 20,000 shares of the business’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the completion of the sale, the chief executive officer now directly owns 269,279 shares in the company, valued at approximately $46,528,718.41. The disclosure for this sale can be found here. Insiders sold a total of 39,506 shares of company stock worth $6,834,758 in the last three months. Insiders own 0.49% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit